Literature DB >> 26049705

A training program for primary care physicians improves the effectiveness of ultrasound surveillance of hepatocellular carcinoma.

Paolo Del Poggio1, Stefano Olmi, Francesca Ciccarese, Marzio Mazzoleni, Michele Jazzetti, Carlo Jamoletti, Mario Mattiello, Anna Del Poggio, Vanessa Portugali, Tommaso Stroffolini.   

Abstract

BACKGROUND AND AIMS: Cirrhosis is the main risk factor of hepatocellular carcinoma (HCC), but only a minority of cirrhotic patients are referred to the hepatologist by primary care physicians (PCP) and receive regular ultrasound surveillance. The aim of this study was to determine whether a training program targeted to PCP could enhance the effectiveness of surveillance in a real-life setting. PATIENTS AND METHODS: A total of 120 PCP in an Italian area with a high incidence of HCC were trained to identify cirrhotic patients, to refer them to the Hepatology Centers of the area, and to start regular ultrasound surveillance. Clinical characteristics, outcome of treatments, and survival of 190 consecutive HCC patients in the same centers after training were compared with 244 HCC referred from the same area before training, and to 232 HCC referred by untrained PCP from other areas.
RESULTS: Trained PCP referred significantly more HCC patients detected under surveillance and at an early stage (Barcelona Clinic Liver Cancer-A), suitable for radical treatments. In the intervention area, the 3 and 5-year survival of HCC patients increased after training from 35 to 48% and from 20 to 40%, respectively (P<0.05). In contrast, survival was unchanged in the other areas. At multivariate analysis, independent predictors adversely affecting survival were Child-Pugh B-C, α-fetoprotein more than 10 ng/dl, nonviral etiology, intermediate/advanced Barcelona Clinic Liver Cancer stage, and referral by an untrained PCP.
CONCLUSION: Specific training of PCP aimed at the identification and referral of cirrhotic patients efficiently improves HCC survival.

Entities:  

Mesh:

Year:  2015        PMID: 26049705     DOI: 10.1097/MEG.0000000000000404

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

1.  Medicine use and medicine-related problems in patients with liver cirrhosis: a systematic review of quantitative and qualitative studies.

Authors:  Ejaz Cheema; Aliaa Al-Aryan; Abdullah Al-Hamid
Journal:  Eur J Clin Pharmacol       Date:  2019-05-11       Impact factor: 2.953

2.  Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance.

Authors:  Amit G Singal; Sarah Reddy; Himani Radadiya Aka Patel; Deyaun Villarreal; Aisha Khan; Yan Liu; Vanessa Cerda; Nicole E Rich; Caitlin C Murphy; Jasmin A Tiro; Jennifer R Kramer; Ruben Hernaez
Journal:  Clin Gastroenterol Hepatol       Date:  2021-12-10       Impact factor: 13.576

3.  Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis.

Authors:  Erin Wolf; Nicole E Rich; Jorge A Marrero; Neehar D Parikh; Amit G Singal
Journal:  Hepatology       Date:  2020-11-20       Impact factor: 17.425

4.  Novel Application of Predictive Modeling: A Tailored Approach to Promoting HCC Surveillance in Patients With Cirrhosis.

Authors:  Amit G Singal; Yixing Chen; Shrihari Sridhar; Vikas Mittal; Hannah Fullington; Muzeeb Shaik; Akbar K Waljee; Jasmin Tiro
Journal:  Clin Gastroenterol Hepatol       Date:  2021-03-02       Impact factor: 13.576

Review 5.  Status of, and strategies for improving, adherence to HCC screening and surveillance.

Authors:  Giampiero Francica; Mauro Borzio
Journal:  J Hepatocell Carcinoma       Date:  2019-07-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.